INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)
Instituto
Hospital Universitari de Girona Dr. Josep Trueta
Girona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (22)
2023
-
A second update on mapping the human genetic architecture of COVID-19
Nature
-
Safety and Efficacy of ApTOLL in Patients with Ischemic Stroke Undergoing Endovascular Treatment: A Phase 1/2 Randomized Clinical Trial
JAMA Neurology, Vol. 80, Núm. 8, pp. 779-788
2022
-
Dyslipidemias and stroke prevention: recommendations of the Study Group of Cerebrovascular Diseases of the Spanish Society of Neurology
Neurologia, Vol. 37, Núm. 1, pp. 61-72
-
Novel genes and sex differences in COVID-19 severity
Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806
2021
-
Stroke prevention in patients with arterial hypertension: Recommendations of the Spanish Society of Neurology's Stroke Study Group
Neurologia, Vol. 36, Núm. 6, pp. 462-471
-
Stroke prevention in patients with type 2 diabetes or prediabetes. Recommendations from the Cerebrovascular Diseases Study Group, Spanish Society of Neurology
Neurologia, Vol. 36, Núm. 4, pp. 305-323
2020
-
Safety and efficacy of intravenous thrombolysis in stroke patients on prior antiplatelet therapy in the WAKE-UP trial
Neurological Research and Practice, Vol. 2, Núm. 1
2019
-
Age- and sex-specific risk profiles and in-hospital mortality in 13,932 Spanish stroke patients
Cerebrovascular Diseases, Vol. 47, Núm. 3-4, pp. 151-164
-
Correlation Between Anti-TNF Serum Levels and Endoscopic Inflammation in Inflammatory Bowel Disease Patients
Digestive Diseases and Sciences, Vol. 64, Núm. 3, pp. 846-854
2017
-
GRECOS Project (Genotyping Recurrence Risk of Stroke): The Use of Genetics to Predict the Vascular Recurrence after Stroke
Stroke, Vol. 48, Núm. 5, pp. 1147-1153
-
Safety and efficacy of thrombectomy in acute ischaemic stroke (REVASCAT): 1-year follow-up of a randomised open-label trial
The Lancet Neurology, Vol. 16, Núm. 5, pp. 369-376
2014
-
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment
Neurologia
-
Safety and efficacy of uric acid in patients with acute stroke (URICO-ICTUS): A randomised, double-blind phase 2b/3 trial
The Lancet Neurology, Vol. 13, Núm. 5, pp. 453-460
2013
-
Recurrent transient ischaemic attack and early risk of stroke: Data from the PROMAPA study
Journal of Neurology, Neurosurgery and Psychiatry, Vol. 84, Núm. 6, pp. 596-603
2012
-
Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: A comparison of prognostic risk scores
Cerebrovascular Diseases, Vol. 33, Núm. 2, pp. 182-189
2011
-
Plan de asistencia sanitaria al ICTUS II. 2010
Neurologia, Vol. 26, Núm. 7, pp. 383-396
2008
-
Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment
Disease Markers, Vol. 25, Núm. 3, pp. 181-188
-
Body temperature and response to thrombolytic therapy in acute ischaemic stroke
European Journal of Neurology, Vol. 15, Núm. 12, pp. 1384-1389
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869
2007
-
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke
Stroke, Vol. 38, Núm. 1, pp. 90-95